GlaxoSmithKline News and Research

RSS

Report reveals cost of type 2 diabetes complications

A first-of-its-kind report looking at the prevalence and cost of type 2 diabetes complications shows that an estimated three out of five people (57.9 percent) with type 2 diabetes have at least one of the other serious health problems commonly associated with the disease, and that these health problems are taking a heavy financial toll on the United States.

11 Apr 2007

FDA approves Twinrix

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved Twinrix [Hepatitis A Vaccine (Inactivated) and Hepatitis B (Recombinant) Vaccine], for an accelerated dosing schedule that consists of three doses given within three weeks followed by a booster dose at 12 months.

4 Apr 2007

GlaxoSmithKline submits Biologics License Application (BLA) for CERVARIX

If licensed, the vaccine will be indicated for the prevention of cervical cancer and precancerous lesions associated with the most common cancer-causing human papillomavirus types.

1 Apr 2007

GlaxoSmithKline files European meningococcal conjugate vaccine

GlaxoSmithKline has announced the submission of a regulatory file to European Medicines Agency (EMEA) under Article 58 for the combination vaccine candidate Globorix (diphtheria, tetanus, pertussis, hepatitis B, Haemophilus influenzae type b, Neisseria meningitides serogroups A and C).

1 Apr 2007

HPV vaccine proposals in Florida, Georgia, North Carolina, South Dakota

Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

22 Mar 2007

Canada budgets $258 million for human papillomavirus vaccination programs

The Canadian government on Monday announced that it is including about $258 million in the 2007-2008 budget to help pay for provincial human papillomavirus vaccination programs, Toronto's Globe and Mail reports.

22 Mar 2007

Pioneer work on cellular response to DNA Damage wins GlaxoSmithKline award

The Biochemical Society's GlaxoSmithKline Award 'for distinguished research leading to new advances in medical science' goes to Stephen Jackson (University of Cambridge) for his pioneering work on cellular response to DNA damage.

22 Mar 2007

Tykerb (lapatinib) - new anti-cancer treatment approved

The Food and Drug Administration (FDA) has approved Tykerb (lapatinib), a new targeted anti-cancer treatment, to be used in combination with capectabine (Xeloda), another cancer drug, for patients with advanced, metastatic breast cancer that is HER2 positive (tumors that exhibit HER2 protein).

14 Mar 2007

Bird flu vaccine - experts say let's try harder

Experts on viruses are calling for a bigger effort to be made in developing vaccines to tackle pandemics.

6 Mar 2007

Safety of Merck's HPV vaccine Gardasil 'lost' in debate

The effectiveness and safety of Merck's human papillomavirus vaccine Gardasil has "been lost" because of Merck's lobbying campaign for mandating vaccination for school attendance, and the "real losers" might be "girls and women who need access" to the vaccine, Boston Globe columnist Ellen Goodman writes in an opinion piece .

5 Mar 2007

Actions taken on HPV vaccine proposals in Kentucky, Massachusetts, New Mexico, Ohio, South Dakota and Virginia

4 Mar 2007

Lawmakers should not make HPV vaccination mandatory, CDC advisory panel chair says

Jon Abramson, chair of CDC's Advisory Committee on Immunization Practices, recently said that he does not support mandating human papillomavirus vaccination for school attendance, the Washington Times reports.

1 Mar 2007

State actions on human papillomavirus vaccine proposals

The following highlights recent news of state actions on human papillomavirus vaccine proposals. Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

25 Feb 2007

Texas Gov. Perry says Merck campaign contribution had no effect on decision to mandate Gardasil

Texas Gov. Rick Perry (R) on Thursday said that contributions made by a Merck political action committee to his campaign had no influence on his decision to issue an executive order requiring that all girls entering the sixth grade receive a human papillomavirus vaccine, the AP/International Herald Tribune reports

25 Feb 2007

Herpes treatment could slow HIV progression in people living with both viruses

Treatment of genital herpes could slow the progression of HIV in people living with both viruses, according to a study published in the Feb. 22 issue of the New England Journal of Medicine.

25 Feb 2007

Some health experts concerned proponents of mandatory HPV vaccination are acting too soon

Some public health experts recently have expressed concern that proponents of human papillomavirus vaccination legislation -- including Merck, producer of the HPV vaccine Gardasil -- have acted "far too fast" and are "potentially undermining eventual prospects for the broadest possible immunization," the New York Times reports .

22 Feb 2007

Merck pledges to stop lobbying States on Gardasil

Merck has decided to suspend its campaign to lobby for state proposals that would mandate girls receive its human papillomavirus vaccine Gardasil in light of opposition from some parents, patient advocacy groups and public health officials, the Wall Street Journal reports.

22 Feb 2007

Jesse Jackson urges HIV awareness, testing, more research for a cure

The Rev. Jesse Jackson on Monday in Philadelphia at the 2007 National Conference on African-Americans and AIDS called for increased research funding to find a cure for HIV/AIDS, as well as more awareness about HIV testing, the Philadelphia Inquirer reports.

19 Feb 2007

Texas lawmakers ask Gov. Perry to rescind order mandating HPV vaccination for girls entering sixth grade

Thirty-two Texas lawmakers last Thursday sent a letter to Gov. Rick Perry (R) reiterating their plea for him to rescind an executive order that would mandate vaccination against human papillomavirus for girls entering the sixth grade, the AP/Dallas Morning News reports.

13 Feb 2007